NCT03362164Recruiting
Evaluation of HEArt invoLvement in Patients With FABRY Disease
Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease
Source: ClinicalTrials.gov · Last updated 7 Jul 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 650 (estimated)
- First submitted
- 29 Nov 2017
- Start date
- 1 Jan 2001
- Primary completion date
- 31 Mar 2032
- Lead sponsor
- Wuerzburg University Hospital
- NCT number
- NCT03362164
What you commit to
- Study type: Observational
- Planned participants: 650
- From 1 Jan 2001 to the primary completion date, 31 Mar 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No informed consent
- Withdrawal of informed consent
Who the study is looking for
- Fabry disease (genetically confirmed)
- Signed informed consent
- 18 years and older
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wuerzburg University Hospital Coordinator of this site? Confirm its status | Würzburg | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.